BOOTHBAY FUND MANAGEMENT, LLC - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 114 filers reported holding RELMADA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.0%.

Quarter-by-quarter ownership
BOOTHBAY FUND MANAGEMENT, LLC ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$31,468
+8.8%
12,7920.0%0.00%0.0%
Q1 2023$28,910
-35.2%
12,7920.0%0.00%0.0%
Q4 2022$44,644
-99.6%
12,792
-95.3%
0.00%
-99.6%
Q3 2022$10,106,000
+612.7%
273,000
+265.5%
0.25%
+581.1%
Q2 2022$1,418,000
-23.4%
74,700
+29.1%
0.04%
-37.3%
Q2 2021$1,852,000
+58.4%
57,853
+74.2%
0.06%
+34.1%
Q1 2021$1,169,00033,2110.04%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Guild Investment Management, Inc. 205,300$615,9001.03%
Deep Track Capital, LP 2,837,818$8,513,4540.33%
PARSONS CAPITAL MANAGEMENT INC/RI 974,082$2,922,2460.23%
apricus wealth, LLC 77,362$239,8220.21%
Palo Alto Investors LP 732,400$2,197,2000.21%
RTW INVESTMENTS, LP 2,131,835$6,395,5050.14%
SILVERARC CAPITAL MANAGEMENT, LLC 100,000$300,0000.09%
AdvisorShares Investments LLC 112,908$338,7240.09%
Savior LLC 3,500$10,5000.07%
Spotlight Asset Group, Inc. 20,000$60,0000.05%
View complete list of RELMADA THERAPEUTICS INC shareholders